Alzene

N/A

Report date: 2023/11/13 20:04:07
NME

Base Information

Drug NameAlzene
Drug Alias Namealpha-Linolenic acid/linoleic acidAlzeneSR-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 4 agonists
TargetsFree fatty acid receptor 4
Therapy Area/IndicationsAutism Spectrum DisorderAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBangladesh
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBar Ilan University
China Registration ClassN/A

Develop Information

Active IndicationsAutism Spectrum Disorder
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A